EXEL Exelixis Inc

Exelixis Inc is a part of the healthcare sector. As a biotechnology company, it develops small molecule therapies for the treatment of cancer.

$16.34  +0.66 (4.21%)
As of 10/03/2022 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/15/2001
Outstanding shares:  321,831,784
Average volume:  2,214,238
Market cap:   $5,097,815,459
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2576941
Valuation   (See tab for details)
PE ratio:   24.99
PB ratio:   2.19
PS ratio:   0.00
Return on equity:   12.99%
Net income %:   19.60%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy